SURFACE MODIFICATION TO IMPROVE CELL ADHESION IN BIOREACTORS

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: N/A
Agency Tracking Number: 7472
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1988
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Bio-metric Systems Inc
9924 West Seventy-fourth St, Eden Prairie, MN, 55344
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 PETER NASH PHD
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract
SCIENTIFIC AND REGULATORY CONSIDERATIONS DICTATE THAT MANY VACCINES AND GENETICALLY ENGINEERED PROTEINS FOR USE IN IN HUMANS ARE BEST PRODUCED IN MAMMALIAN CELL LINES DERIVED FROM NON-MALIGNANT SOURCES. THESE CELLS USUALLY REQUIRE A SURFACE UPON WHICH TO GROW, AND SEVERAL BIOREACTOR CONFIGURATIONS HAVE BEEN DEVELOPED WHICH HAVE LARGE SURFACE AREAS COMPRESSED INTO SMALL VOLUMES, THEREBY IMPROVING THE EFFICIENCY OF THE SYSTEM. CURRENTLY, HOWEVER, THE INTERNAL SURFACES ARE NOT ADEQUATE FOR LONG-TERM CELL CULTURE; THE GREATEST PROBLEM IS THAT CELLS TYPICALLY DIE DETACH AFTER FOUR TO SIX WEEKS, THUS GREATLY LIMITING THE USEFUL LIFE OF SUCH BIOREACTORS. IN PHASE I, WE PROPOSETO COVALENTLY IMMOBILIZE NATURALLY OCCURRING CELL ADHESION PROTEINS ONTO SURFACES SUITABLE FOR LARGE-SCALE CELL CULTURE, AND THEN TEST THEIR EFFECTIVENESS IN IMPROVING INITIAL CELL ATTACHMENT, CELL GROWTH, AND LONG-TERM VIABILITY USING THREE REPRESENTATIVE CELL LINES. IN PHASE II, WE PROPOSE TO CONDUCT MORE EXTENSIVE LONG-TERM EVALUATIONS, TEST VARIOUS CELL LINES, AND INVESTIGATE CELL GROWTH IN SERUM-FREE MEDIA. PROOF-OF-CONCEPT OF THIS TECHNOLOGY SHOULD GREATLY IMPROVE THE USEFULNESS OF BIOREACTORS IN PRODUCING CERTAIN PROTEINS FOR PHARMACEUTICAL USE.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government